CH476673A - Verfahren zur Herstellung von Salzen von Adamantan- und Tricyclo(4,3,1,13,8)undecanverbindungen - Google Patents

Verfahren zur Herstellung von Salzen von Adamantan- und Tricyclo(4,3,1,13,8)undecanverbindungen

Info

Publication number
CH476673A
CH476673A CH946964A CH946964A CH476673A CH 476673 A CH476673 A CH 476673A CH 946964 A CH946964 A CH 946964A CH 946964 A CH946964 A CH 946964A CH 476673 A CH476673 A CH 476673A
Authority
CH
Switzerland
Prior art keywords
tricyclo
adamantane
salts
preparation
undecane compounds
Prior art date
Application number
CH946964A
Other languages
English (en)
Inventor
W Prichard William
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of CH476673A publication Critical patent/CH476673A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/29Saturated compounds containing keto groups bound to rings
    • C07C49/313Saturated compounds containing keto groups bound to rings polycyclic
    • C07C49/323Saturated compounds containing keto groups bound to rings polycyclic having keto groups bound to condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH946964A 1963-07-24 1964-07-20 Verfahren zur Herstellung von Salzen von Adamantan- und Tricyclo(4,3,1,13,8)undecanverbindungen CH476673A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29723363A 1963-07-24 1963-07-24
US376259A US3352912A (en) 1963-07-24 1964-06-18 Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes

Publications (1)

Publication Number Publication Date
CH476673A true CH476673A (de) 1969-08-15

Family

ID=26970055

Family Applications (2)

Application Number Title Priority Date Filing Date
CH946964A CH476673A (de) 1963-07-24 1964-07-20 Verfahren zur Herstellung von Salzen von Adamantan- und Tricyclo(4,3,1,13,8)undecanverbindungen
CH1457468A CH479535A (de) 1963-07-24 1964-07-20 Verfahren zur Herstellung von a-Alkyl-l-adamantanmethylaminen und a-Alkyl-3-tricyclo(4,3,1,1 3,8)undecanmethylaminen

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1457468A CH479535A (de) 1963-07-24 1964-07-20 Verfahren zur Herstellung von a-Alkyl-l-adamantanmethylaminen und a-Alkyl-3-tricyclo(4,3,1,1 3,8)undecanmethylaminen

Country Status (14)

Country Link
US (1) US3352912A (de)
AT (1) AT279581B (de)
BE (1) BE650919A (de)
BR (1) BR6460975D0 (de)
CH (2) CH476673A (de)
DE (3) DE1793207A1 (de)
DK (3) DK112027B (de)
ES (1) ES302369A1 (de)
FI (3) FI42322B (de)
FR (1) FR1572956A (de)
GB (1) GB1069563A (de)
IL (1) IL21753A (de)
NL (2) NL6408505A (de)
SE (3) SE321924B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449422A (en) * 1966-02-09 1969-06-10 Smithkline Corp Pentacycloundecane amines
DE1294371B (de) * 1966-12-21 1969-05-08 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung von 1-Aminoadamantan und dessen N-Alkyl- bzw. N-Cyclohexylderivaten
US3489802A (en) * 1967-01-23 1970-01-13 Du Pont Preparation of alpha-methyl-1-adamantane-methylamine and alpha,4 - dimethyl - 1 - bicyclo(2,2,2)octane methylamine
NL6900004A (de) * 1969-01-02 1970-07-06
US3682922A (en) * 1969-01-16 1972-08-08 Searle & Co N-acyl-n-{8 (n{40 ,n{40 -disubstituted amino)-alkyl{9 -1-adamantylmethylamines
JPS4828903B1 (de) * 1969-07-19 1973-09-05
US3624086A (en) * 1969-11-10 1971-11-30 Searle & Co Adamantanecarboxamidoalkanoic acid amides
US3852339A (en) * 1970-06-15 1974-12-03 Squibb & Sons Inc Aminoalkoxyphenylurea derivatives
US3879400A (en) * 1973-11-16 1975-04-22 Upjohn Co 1-Lower alkyl-(1-adamantylmethyl)piperidines and process for their preparation
JPS5346950A (en) * 1976-10-12 1978-04-27 Kao Corp (54)1-acetylaminotricyclo(4,3,1,12,5)undecane and its preparation
US4351847A (en) * 1981-06-26 1982-09-28 Pennwalt Corporation Antiviral alpha, alpha-dialkyl adamantylethylamines
US4551552A (en) * 1984-05-23 1985-11-05 E. I. Du Pont De Nemours And Company Process for preparing rimantadine
US4751245A (en) * 1986-06-25 1988-06-14 E. R. Squibb & Sons, Inc. Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
US5576355A (en) * 1993-06-04 1996-11-19 Mobil Oil Corp. Diamondoid derivatives for pharmaceutical use
US5684024A (en) * 1996-01-25 1997-11-04 Viropharma Incorporated Pyrazole dimers compositions and methods for treating influenza
US5821243A (en) 1996-07-22 1998-10-13 Viropharma Incorporated Compounds compositions and methods for treating influenza
PT870757E (pt) * 1997-04-10 2002-09-30 Pfizer Derivados de adamantano substituidos por fluoro
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
WO2003004461A1 (en) * 2001-07-02 2003-01-16 Schering Corporation Drugs for treating viral infections
SE0103836D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
EP2266590A3 (de) 2002-02-22 2011-04-20 Shire LLC Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen
WO2004056744A1 (en) * 2002-12-23 2004-07-08 Janssen Pharmaceutica N.V. Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
SE0300480D0 (sv) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
EP2314574A1 (de) * 2005-06-17 2011-04-27 Apogee Biothechnology Corporation Sphingosin-Kinaseinhibitoren
AR057623A1 (es) 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd Materiales y metodos para el tratamiento de las infecciones virales
WO2008114002A1 (en) 2007-03-22 2008-09-25 Astrazeneca Ab Quinoline derivatives for the treatment of inflammatory diseases
PE20091036A1 (es) 2007-11-30 2009-08-15 Astrazeneca Ab Derivado de quinolina como antagonista del receptor p2x7
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
CN105829284B (zh) * 2013-12-09 2019-01-22 荷兰联合利华有限公司 制备金刚烷甲酰胺类化合物的方法
EP3383429B1 (de) 2015-11-30 2020-10-14 INSERM - Institut National de la Santé et de la Recherche Médicale Nmdar antagonisten zur behandlung von krebs angiogenese
WO2019018185A1 (en) * 2017-07-15 2019-01-24 Arisan Therapeutics Inc. ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS

Also Published As

Publication number Publication date
SE321924B (de) 1970-03-23
NL7102097A (de) 1971-05-25
DK114769B (da) 1969-08-04
US3352912A (en) 1967-11-14
FR1572956A (de) 1969-07-04
BE650919A (de) 1964-11-16
CH479535A (de) 1969-10-15
FI42322B (de) 1970-03-31
AT279581B (de) 1970-03-10
DK114199B (da) 1969-06-09
GB1069563A (en) 1967-05-17
SE320363B (de) 1970-02-09
SE330693B (de) 1970-11-30
FI42211B (de) 1970-03-02
ES302369A1 (es) 1965-03-16
DK112027B (da) 1968-11-04
FI42548B (de) 1970-06-01
BR6460975D0 (pt) 1973-08-09
IL21753A (en) 1968-01-25
DE1793207A1 (de) 1972-03-30
DE1793208A1 (de) 1972-04-06
DE1792295B1 (de) 1971-05-27
DE1468769B1 (de) 1972-06-29
NL6408505A (de) 1965-01-25

Similar Documents

Publication Publication Date Title
CH476673A (de) Verfahren zur Herstellung von Salzen von Adamantan- und Tricyclo(4,3,1,13,8)undecanverbindungen
CH481924A (de) Verfahren zur Herstellung von 6-Aminophenyl- und 6-Acylaminophenyl-4,5-dihydropyridazonen (3)
CH468966A (de) Verfahren zur Herstellung von 3-Aminotricyclo-(4,3,1,1,3,8)-undecan
CH437316A (de) Verfahren zur Herstellung von substituierten Phenyl-amino-1,3-diazacyclopenten-(2)-Verbindungen
CH459196A (de) Verfahren zur Herstellung von 4,6-Pregnadienderivaten
CH458587A (de) Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon
CH479574A (de) Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden
CH460766A (de) Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden
CH481935A (de) Verfahren zur Herstellung von N-Acyl-3,4-dihydrooxazinen-(1,3)
CH484047A (de) Verfahren zur Herstellung von Adamantanverbindungen
CH436317A (de) Verfahren zur Herstellung von 5-Joduracil-2'-desoxyribosid-3',5'-di-Estern
CH437320A (de) Verfahren zur Herstellung von 4-Amino-5-hydroxypyridazonen (6)
CH441352A (de) Verfahren zur Herstellung von 1-Phenyl-3-butyl-4-methyl-triazolon-(5)
CH462803A (de) Verfahren zur Herstellung von (2-Aminocycloalkyl)-hydrochinonen
CH481939A (de) Verfahren zur Herstellung von 4H-Pyrazino-(2,3-d)-(1,3)-oxazin-4-onen
CH435245A (de) Verfahren zur Herstellung von 1-Aryl-perchlor-2-aza-alkenen-(2)
AT247848B (de) Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen
CH439328A (de) Verfahren zur Herstellung von 3,5-Dijodthyroninen
CH441583A (de) Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen
CH444154A (de) Verfahren zur Herstellung von 1(10),2,4a(5)-A-Homoöstratrien-4-onderivaten
CH427830A (de) Verfahren zur Herstellung von substituierten 1,4-Benzodiazepinen
AT266800B (de) Verfahren zur Herstellung von 2-Thiapropandiol-(1,3)
CH446359A (de) Verfahren zur Herstellung von 4-Nitro-5-chlor- bzw. -brom-pyridazonen-(6)
AT253703B (de) Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden
CH437595A (de) Verfahren zur Herstellung von substituierten a-Phenylaminoanthrachinonfarbstoffen

Legal Events

Date Code Title Description
PL Patent ceased